Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis.
Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica.
Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme Activity.
Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment.
Neuromyelitis optica: Evaluation of 871 attacks and 1153 treatment courses.
Development of cladribine at Scripps for hairy cell leukemia and current results.
Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis.
Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
Paraoxonase 1 activity in multiple sclerosis patients during mitoxantrone therapy.
Biogen Idec submits application to FDA for approval of PLEGRIDY™ (peginterferon beta-1a) in multiple sclerosis
Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS.
The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
Current and future disease-modifying therapies in multiple sclerosis.
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE).
Tcelna® (imilecleucel-T)
Withdrawal of the marketing authorization in the European Union
Urodynamic and physiologic patterns associated with the common causes of neurogenic bladder in adults.
Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone.
Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis.
Daclizumab discontinue letter for the US market
Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy.
Raxone®/Catena® (idebenone)
Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis.
Zebrafish myelination: a transparent model for remyelination?
Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration.

Pages